• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

Senesco Technologies

edit

Senesco Technologies, Inc., a development stage biotechnology company, focuses on the development of technologies to treat programmed cell death diseases in humans. Its technologies are also used to enhance the productivity of fruits, flowers, vegetables, forestry species, and agronomic crops through the control of cell death in plants. The company was founded in 1964 and is headquartered in Bridgewater, New Jersey.

Milestones

edit

• 
  Senesco Technologies added Leslie J. Browne as President and CEO.
  Posted 7/20/10 at 7:30pm
• 
  Went public with stock symbol AMEX:SNT.
  Posted 7/20/10 at 7:31pm
• 
  Senesco Technologies received $11.5M in Venture Round funding. (3/29/10)
  Posted 7/20/10 at 7:30pm via senesco.com

Videos

Screenshots

edit

Stock Price

Sources

1. Senesco Technologies, Inc. Announces Private Placement Financing for Gross Proceeds of $11.5 Million. Funds to be Utilized to Advance Lead Multiple Myeloma Drug Candidate into Phase 1b/2a Clinical Trial (senesco.com) [edit]